月经液中子宫内膜干/祖细胞与上清蛋白含量的周期性变化及指示范围
该研究纳入11名月经周期规律且近3个月未用激素药物的非妊娠女性,用硅胶月经杯在月经第2天采集最多5个周期的月经液。结果显示部分子宫内膜干/祖细胞比例及selected蛋白丰度在个体内和个体间变异有限,提示单次月经样本可能足以表征多种细胞和蛋白参数。
要点
- 月经液可检测到具有克隆形成能力的子宫内膜干/祖细胞。
- SUSD2+ eMSC等细胞类型个体内一致性中等至良好(ICC 0.52-0.75)。
- 八种炎症/修复蛋白中五种个体内一致性中等(ICC 0.57-0.69)。
核心结论
- 月经液中部分子宫内膜干/祖细胞百分比和选定蛋白丰度在个体内及个体间变异有限。
- 单次月经样本可能足以表征女性多个周期中的多种细胞和蛋白参数。
研究设计与样本
- 研究纳入11名月经周期规律、近3个月未使用激素药物的非妊娠女性。
- 参与者使用硅胶月经杯在月经第2天采集最多5个周期的月经液。
主要发现
- 月经液中的子宫内膜干/祖细胞具有克隆形成特性。
- SUSD2+ MF-eMSC、SSEA-1+ MF-eEPC、NCAD+SSEA-1+ MF-eEPC及基质克隆形成能力的个体内一致性ICC分别为0.75、0.56、0.54和0.52。
- 八种炎症和修复蛋白中五种(SLPI、NGAL、乳铁蛋白、FSTL1、HE4)个体内一致性中等,ICC范围0.57-0.69。
- 健康参与者个体间变异有限,但部分自报月经病理的离群值例外。
临床怎么用
- 月经液可作为子宫内膜干/祖细胞及相关蛋白的可靠来源,具有诊断潜力。
- 在研究和临床中,单次月经样本可能足以表征多种细胞和蛋白参数。
- 月经液有望作为无创方法用于评估子宫内膜健康及识别异常。
局限性
- 难以在多个月经周期中一致地获取月经液样本。
- 部分参与者仅能提供少于3个周期的样本,月经杯佩戴时长在4至6小时之间变化。
- 样本量有限,需更大规模且连续多周期的研究来确定正常范围。
- 需考虑选择偏倚及人群代表性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does natural variation exist in the endometrial stem/progenitor cell and protein composition of menstrual fluid across menstrual cycles in women? SUMMARY ANSWER: Limited variation exists in the percentage of some endometrial stem/progenitor cell types and abundance of selected proteins in menstrual fluid within and between a cohort of women. WHAT IS KNOWN ALREADY: Menstrual fluid is a readily available biofluid that can represent the endometrial environment, containing endometrial stem/progenitor cells and protein factors. It is unknown whether there is natural variation in the cellular and protein content across menstrual cycles of individual women, which has significant implications for the use of menstrual fluid in research and clinical applications. STUDY DESIGN, SIZE, DURATION: Menstrual fluid was collected from 11 non-pregnant females with regular menstrual cycles. Participants had not used hormonal medications in the previous 3 months. Participants collected menstrual fluid samples from up to five cycles using a silicone menstrual cup worn on Day 2 of menstrual bleeding. PARTICIPANTS/MATERIALS, SETTING, METHODS: Menstrual fluid samples were centrifuged to separate soluble proteins and cells. Cells were depleted of red blood cells and CD45+ leucocytes. Menstrual fluid-derived endometrial stem/progenitor cells were characterized using multicolour flow cytometry including markers for endometrial stem/progenitor cells N-cadherin (NCAD) and stage-specific embryonic antigen-1 (SSEA-1) (for endometrial epithelial progenitor cells; eEPC), and sushi domain containing-2 (SUSD2) (for endometrial mesenchymal stem cells; eMSC). The clonogenicity of menstrual fluid-derived endometrial cells was assessed using colony forming unit assays. Menstrual fluid supernatant was analyzed using a custom magnetic Luminex assay. MAIN RESULTS AND THE ROLE OF CHANCE: Endometrial stem/progenitor cells are shed in menstrual fluid and demonstrate clonogenic properties. The intraparticipant agreement for SUSD2+ menstrual fluid-derived eMSC (MF-eMSC), SSEA-1+ and NCAD+SSEA-1+ MF-eEPC, and stromal clonogenicity were moderate-good (intraclass correlation; ICC: 0.75, 0.56, 0.54 and 0.52, respectively), indicating limited variability across menstrual cycles. Endometrial inflammatory and repair proteins were detectable in menstrual fluid supernatant, with five of eight (63%) factors demonstrating moderate intraparticipant agreement (secretory leukocyte protein inhibitor (SLPI), lipocalin-2 (NGAL), lactoferrin, follistatin-like 1 (FSTL1), human epididymis protein-4 (HE4); ICC ranges: 0.57-0.69). Interparticipant variation was limited for healthy participants, with the exception of key outliers of which some had self-reported menstrual pathologies. LARGE SCALE DATA: N/A. There are no OMICS or other data sets relevant to this study. LIMITATIONS, REASONS FOR CAUTION: The main limitations to this research relate to the difficulty of obtaining menstrual fluid samples across multiple menstrual cycles in a consistent manner. Several participants could only donate across <3 cycles and the duration of wearing the menstrual cup varied between 4 and 6 h within and between women. Due to the limited sample size used in this study, wider studies involving multiple consecutive menstrual cycles and a larger cohort of women will be required to fully determine the normal range of endometrial stem/progenitor cell and supernatant protein content of menstrual fluid. Possibility for selection bias and true representation of the population of women should also be considered. WIDER IMPLICATIONS OF THE FINDINGS: Menstrual fluid is a reliable source of endometrial stem/progenitor cells and related endometrial proteins with diagnostic potential. The present study indicates that a single menstrual sample may be sufficient in characterizing a variety of cellular and protein parameters across women's menstrual cycles. The results also demonstrate the potential of menstrual fluid for identifying endometrial and menstrual abnormalities in both research and clinical settings as a non-invasive method for assessing endometrial health. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by grants from the Australian National Health and Medical Research Council to C.E.G. (Senior Research Fellowship 1024298 and Investigator Fellowship 1173882) and to J.E. (project grant 1047756), the Monash IVF Research Foundation to C.E.G. and the Victorian Government's Operational Infrastructure Support Program. K.A.W., M.L.D.-T., S.G.S. and J.E. declare no conflicts of interest. C.E.G. reports grants from NHMRC, during the conduct of the study; grants from EndoFound USA, grants from Ferring Research Innovation, grants from United States Department of Defence, grants from Clue-Utopia Research Foundation, outside the submitted work. CEF reports grants from EndoFound USA, grants from Clue-Utopia Research Foundation, outside the submitted work.
引用
- Wyatt KA, Filby CE, Davies-Tuck ML, et al. Menstrual fluid endometrial stem/progenitor cell and supernatant protein content: cyclical variation and indicative range. Hum Reprod. 2021. PMID: 34173001. doi:10.1093/humrep/deab156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。